Thymosin Beta-4 (TB-500) works through different mechanisms than BPC-157, primarily promoting cell migration and differentiation rather than angiogenesis
Angesichts der Tatsache, dass alle diese Modelle zum Screening der Mittel eingesetzt werden, die derzeit in der Therapie von gastrointestinalen Lsionen verwendet werden, und der reproduzierbar gnstigen Wirkungen von NaBPC157, ist seine gnstige Anwendung bei der Therapie der Lsionen des gesamten Intestinaltrakts offensichtlich
Product range includes BPC-157, available as a standalone peptide or in a blended formulation: (1) M.J.Hsieh et al (2016) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation Journal of Molecular Medicine, 15 November 2016, Volume 95, pages 323333
Biologics like anti-tumor necrosis factor-alpha (TNF-) agents are more effective, with response rates of 60 - 70% of cases, but increase infection risks and are cost-prohibitive (6)